These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3608052)

  • 21. Thyroid status in malignant hyperpyrexia.
    Lister D
    Br J Anaesth; 1973 Jan; 45(1):115. PubMed ID: 4696420
    [No Abstract]   [Full Text] [Related]  

  • 22. Erythrocyte osmotic fragility testing and the prediction of canine malignant hyperthermia susceptibility.
    Cribb PH; Olfert EA; Reynolds FB
    Can Vet J; 1986 Dec; 27(12):517-22. PubMed ID: 17422730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation for malignant hyperthermia susceptibility in black-tailed deer.
    Antognini JF; Eisele PH; Gronert GA
    J Wildl Dis; 1996 Oct; 32(4):678-81. PubMed ID: 9359070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet model for halothane-induced effects on nucleotide metabolism applied to malignant hyperthermia.
    Solomons CC; Masson NC
    Acta Anaesthesiol Scand; 1984 Apr; 28(2):185-90. PubMed ID: 6730881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland].
    Urwyler A; Censier K; Seeberger MD; Drewe J; Rothenbühler JM; Frei F
    Schweiz Med Wochenschr; 1991 Apr; 121(16):566-71. PubMed ID: 2042040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in cytoplasmic free calcium caused by halothane. Role of the plasma membrane and intracellular Ca2+ stores.
    Klip A; Britt BA; Elliott ME; Walker D; Ramlal T; Pegg W
    Biochem Cell Biol; 1986 Nov; 64(11):1181-9. PubMed ID: 3828110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of neuroleptic agents on rat skeletal muscle contracture in vitro.
    Hon CA; Landers DF; Platts AA
    Anesth Analg; 1991 Feb; 72(2):194-202. PubMed ID: 1670755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Examination of the family of a patient susceptible to anesthetic malignant hyperthermia].
    Krivosic-Horber R; Theunynck D; Krivosic I; Adnet P; Guévart E
    Ann Fr Anesth Reanim; 1986; 5(3):326-9. PubMed ID: 3777561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Screening tests for malignant hyperthermia susceptibility].
    Krivosic-Horber R; Adnet P
    Ann Fr Anesth Reanim; 1989; 8(5):444-56. PubMed ID: 2560612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum myoglobin levels following administration of succinylcholine during nitrous oxide-oxygen-halothane anesthesia (author's transl)].
    Inagaki M; Koyama A; Sakata S; Tonogai R; Yamada Y; Kawai H; Iwasa M; Kondo A; Miyoshi K
    Masui; 1980 Nov; 29(12):1476-82. PubMed ID: 7463707
    [No Abstract]   [Full Text] [Related]  

  • 31. In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?
    Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
    Eur J Anaesthesiol; 2011 Apr; 28(4):251-5. PubMed ID: 20827211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diltiazem and nifedipine reduce the in vitro contracture response to halothane in malignant hyperthermia-susceptible muscle.
    Adnet PJ; Krivosic-Horber RM; Haudecoeur G; Reyford HG; Adamantidis MM; Dupuis BA
    Can J Anaesth; 1990 Jul; 37(5):556-9. PubMed ID: 2372858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of greyhound susceptibility to malignant hyperthermia using halothane-succinylcholine anesthesia and caffeine-halothane muscle contractures.
    Cosgrove SB; Eisele PH; Martucci RW; Gronert GA
    Lab Anim Sci; 1992 Oct; 42(5):482-5. PubMed ID: 1460848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Contracture responses of the muscle from a patient with malignant hyperthermia to drugs].
    Iwatsuki N; Koga Y; Amaha K
    Masui; 1984 Jul; 33(7):731-6. PubMed ID: 6502923
    [No Abstract]   [Full Text] [Related]  

  • 35. Perfusion of malignant hyperthermia susceptible and normal isolated pig livers with halothane.
    Britt BA; Shandling B; Endrenyl L; Kent GM
    Can Anaesth Soc J; 1978 Sep; 25(5):373-9. PubMed ID: 698870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity of the adenine nucleotide metabolism of platelets from malignant hyperthermia patients to halothane.
    Hofmann JG; Büttner C; Till U
    Biomed Biochim Acta; 1989; 48(4):343-50. PubMed ID: 2751640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Determination of intracellular free calcium concentration, in vivo, in swine susceptible to malignant hyperthermia syndrome].
    López JR; Alamo LA; Jones D; Papp L; Allen P; Gergely J; Streter F
    Acta Cient Venez; 1985; 36(1):102-4. PubMed ID: 4090898
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of spin resonance spectroscopy of red blood cell membranes to detect malignant hyperthermia susceptibility.
    Halsall PJ; Ellis FR; Knowles PF
    Br J Anaesth; 1992 Nov; 69(5):471-3. PubMed ID: 1334685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A halothane-induced biochemical defect in muscle of normal and malignant hyperthermia-susceptible Landrace pigs.
    Mitchell G; Heffron JJ; van Rensburg AJ
    Anesth Analg; 1980 Apr; 59(4):250-6. PubMed ID: 7189363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of ryanodine on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis.
    Bina S; Muldoon S; Bünger R
    Eur J Anaesthesiol; 2008 Jan; 25(1):48-57. PubMed ID: 17686208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.